Villamor, Erlinda N.
HRN: 20-49-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/17/2022
11/23/2022
IV
4.5gram
Q8hrs
T/C Aspiration Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes